Open Invitation to Join Session 11 of PH 236:
US Food and Drug Administration, Drug Development, Science and Health Policy
Session 11: Response to Global HIV and HCV Epidemics
April 9, 2015 * Stanley Hall 105, UC Berkeley * 6:30-8:30 PM
**Networking reception: 5:45-6:30 PM**
Stefano Bertozzi, MD, PhD: Dean, School of Public Health; former Director of HIV at the Bill & Melinda Gates Foundation Ambassador Eric Goosby, MD: Global Health Sciences, UCSF; former Global AIDS Coordinator Gaston Picchio, PhD: Vice President, Hepatitis Disease Area/Global Virology, Janssen Research & Development, LLC Jim Rooney, MD: Vice President of Medical Affairs, Gilead Sciences, Inc. Anil Soni: Global Commercial Leader, Infectious Diseases, Mylan, Inc.
Course Co-Instructor and Moderator:
Veronica Miller, PhD: Executive Director, Forum for Collaborative HIV Research
PH 236 Session 11 caps PH 236 lecture content by recruiting five global health experts to discuss the role and responsibilities of public and private organizations in the response to the global HIV and HCV epidemics. From policy advances to facilitate access to life saving antiretrovirals for millions of patients, to challenges in regulatory infrastructure, to the rocky path for point-of-care diagnostics and treatment monitoring technologies, to the recognition that treatment is prevention and key to any containment strategy – the lessons provided by the expansion and entrenchment of the HIV epidemic, and successes and failures in the public health response are unparalleled in the global health arena. The growing recognition that the HCV epidemic offers equally imperative opportunities and deserves just as strong a response is a chance to reflect on these lessons and find ways to move forward without stumbling on many of the issues already encountered in HIV. The perspectives and reflections of these five global health leaders on these topics provide an exclusive and unique window on global health and will be of great interest to the wider Berkeley, UCSF and Bay Area community.
Grounded in the work of Berkeley School of Public Health’s Forum for Collaborative HIV Research, PH 236 introduces Berkeley, UCSF and UC Davis students, visiting scholars and post-docs to the basics of drug development and regulatory policies emphasizing the role and benefit of multi-stakeholder engagement. Students and VSPA affiliates have learned how the US Food and Drug Administration responded to the public health challenge presented by the HIV, HCV and liver disease epidemics by adapting regulatory policies to expedite and accelerate drug approval so that more patients could access life-prolonging and life-saving drugs. The course includes guest lecturers from the Forum’s academic and biotech partners in the Bay Area. The course, taught by instructors Veronica Miller and Jur Strobos, is designed for students and postdocs interested in careers in biotech, regulatory science or federal health policy.